Mary E. Law

674 total citations
22 papers, 514 citations indexed

About

Mary E. Law is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mary E. Law has authored 22 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Mary E. Law's work include Cancer-related Molecular Pathways (8 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Ubiquitin and proteasome pathways (4 papers). Mary E. Law is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Ubiquitin and proteasome pathways (4 papers). Mary E. Law collaborates with scholars based in United States, Denmark and Taiwan. Mary E. Law's co-authors include Brian K. Law, Patrick Corsino, Ronald K. Castellano, Bradley J. Davis, Mengxiong Wang, Satya Narayan, Stephan C. Jahn, Thomas C. Rowe, Renan B. Ferreira and Peter Nørgaard and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Mary E. Law

22 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Law United States 14 303 188 167 71 70 22 514
Liang-Ping Xia China 9 206 0.7× 181 1.0× 102 0.6× 48 0.7× 74 1.1× 13 424
Kaushlendra Tripathi United States 17 521 1.7× 223 1.2× 126 0.8× 45 0.6× 42 0.6× 31 718
Liqing Zhuang Australia 7 345 1.1× 200 1.1× 92 0.6× 93 1.3× 49 0.7× 7 535
Dmytro Starenki United States 16 458 1.5× 235 1.3× 89 0.5× 102 1.4× 51 0.7× 28 702
Craig T. Wallington‐Beddoe Australia 14 501 1.7× 143 0.8× 144 0.9× 74 1.0× 76 1.1× 32 658
Ravi Chakra Turaga United States 14 224 0.7× 141 0.8× 126 0.8× 53 0.7× 45 0.6× 16 408
Arpita Datta Singapore 11 423 1.4× 175 0.9× 137 0.8× 121 1.7× 34 0.5× 11 705
Adeline Ledoux United Kingdom 8 341 1.1× 126 0.7× 96 0.6× 78 1.1× 33 0.5× 10 545
Qichao Ni China 14 394 1.3× 149 0.8× 95 0.6× 60 0.8× 39 0.6× 35 567
Yibin Ren China 12 365 1.2× 149 0.8× 68 0.4× 85 1.2× 90 1.3× 13 531

Countries citing papers authored by Mary E. Law

Since Specialization
Citations

This map shows the geographic impact of Mary E. Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Law more than expected).

Fields of papers citing papers by Mary E. Law

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Law. The network helps show where Mary E. Law may publish in the future.

Co-authorship network of co-authors of Mary E. Law

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Law. A scholar is included among the top collaborators of Mary E. Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Law. Mary E. Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Law, Mary E., Young Il Lee, Mengxiong Wang, et al.. (2025). DR5 Disulfide Bonding Functions as a Sensor and Effector of Protein Folding Stress. Molecular Cancer Research. 23(7). 622–639. 1 indexed citations
2.
Ferreira, Renan B., Mary E. Law, Yinuo Yang, et al.. (2022). Anticancer Agents Derived from Cyclic Thiosulfonates: Structure‐Reactivity and Structure‐Activity Relationships. ChemMedChem. 17(14). e202200165–e202200165. 4 indexed citations
3.
Narayan, Satya, Asif Raza, Iqbal Mahmud, et al.. (2022). Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A. iScience. 25(7). 104518–104518. 7 indexed citations
4.
Law, Mary E., Bradley J. Davis, Renan B. Ferreira, et al.. (2022). Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death. Cancer Letters. 534. 215604–215604. 15 indexed citations
5.
Law, Mary E., Bradley J. Davis, Mengxiong Wang, et al.. (2022). Repurposing Tranexamic Acid as an Anticancer Agent. Frontiers in Pharmacology. 12. 792600–792600. 8 indexed citations
6.
Wang, Mengxiong, Mary E. Law, Bradley J. Davis, et al.. (2019). Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway. Cell Death Discovery. 5(1). 153–153. 9 indexed citations
7.
Wang, Mengxiong, Renan B. Ferreira, Mary E. Law, et al.. (2019). A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers. Oncogene. 38(22). 4264–4282. 8 indexed citations
8.
Wang, Mengxiong, Mary E. Law, Ronald K. Castellano, & Brian K. Law. (2018). The unfolded protein response as a target for anticancer therapeutics. Critical Reviews in Oncology/Hematology. 127. 66–79. 99 indexed citations
9.
Law, Mary E., Renan B. Ferreira, Bradley J. Davis, et al.. (2016). CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Research. 18(1). 80–80. 27 indexed citations
10.
Ferreira, Renan B., Mary E. Law, Stephan C. Jahn, et al.. (2015). Novel agents that downregulate EGFR, HER2, and HER3 in parallel. Oncotarget. 6(12). 10445–10459. 24 indexed citations
11.
Law, Mary E., Patrick Corsino, Satya Narayan, & Brian K. Law. (2015). Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics. Molecular Pharmacology. 88(5). 846–852. 80 indexed citations
12.
Jahn, Stephan C., Mary E. Law, Patrick Corsino, et al.. (2014). Signaling Mechanisms that Suppress the Cytostatic Actions of Rapamycin. PLoS ONE. 9(6). e99927–e99927. 4 indexed citations
13.
Jahn, Stephan C., Mary E. Law, Patrick Corsino, et al.. (2013). Assembly, Activation, and Substrate Specificity of Cyclin D1/Cdk2 Complexes. Biochemistry. 52(20). 3489–3501. 15 indexed citations
14.
Jahn, Stephan C., Mary E. Law, Patrick Corsino, et al.. (2012). An in vivo model of epithelial to mesenchymal transition reveals a mitogenic switch. Cancer Letters. 326(2). 183–190. 27 indexed citations
15.
Corsino, Patrick, Nicole A. Horenstein, David A. Ostrov, et al.. (2009). A Novel Class of Cyclin-dependent Kinase Inhibitors Identified by Molecular Docking Act through a Unique Mechanism. Journal of Biological Chemistry. 284(43). 29945–29955. 15 indexed citations
16.
17.
Prasad, Ratna, Xiaohui L. Wang, Brian K. Law, et al.. (2008). Identification of genes, including the gene encoding p27Kip1, regulated by serine 276 phosphorylation of the p65 subunit of NF-κB. Cancer Letters. 275(1). 139–149. 18 indexed citations
18.
Corsino, Patrick, Bradley J. Davis, Peter Nørgaard, et al.. (2008). Mammary Tumors Initiated by Constitutive Cdk2 Activation Contain an Invasive Basal-like Component. Neoplasia. 10(11). 1240–1252. 26 indexed citations
19.
Corsino, Patrick, Bradley J. Davis, Mary E. Law, et al.. (2007). Tumors Initiated by Constitutive Cdk2 Activation Exhibit Transforming Growth Factor β Resistance and Acquire Paracrine Mitogenic Stimulation during Progression. Cancer Research. 67(7). 3135–3144. 20 indexed citations
20.
Law, Mary E., Elizabeth Forrester, Anna Chytil, et al.. (2006). Rapamycin Disrupts Cyclin/Cyclin-Dependent Kinase/p21/Proliferating Cell Nuclear Antigen Complexes and Cyclin D1 Reverses Rapamycin Action by Stabilizing These Complexes. Cancer Research. 66(2). 1070–1080. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang-Ping Xia Breakdown of academic impact, for papers by Kaushlendra Tripathi Breakdown of academic impact, for papers by Liqing Zhuang Breakdown of academic impact, for papers by Dmytro Starenki Breakdown of academic impact, for papers by Craig T. Wallington‐Beddoe Breakdown of academic impact, for papers by Ravi Chakra Turaga Breakdown of academic impact, for papers by Arpita Datta Breakdown of academic impact, for papers by Adeline Ledoux Breakdown of academic impact, for papers by Qichao Ni Breakdown of academic impact, for papers by Yibin Ren
Rankless by CCL
2026